James Krueger
Dermatology · New York, NYNPI 1821307703
Payments from drug & device makers
Across 729 payments — averaging $8656.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2.4M
- AbbVie$1.3M
- Takeda Pharmaceuticals U.S.A., Inc.$863K
- Novartis Pharma AG$622K
- Pfizer$460K
- E.r. Squibb & Sons, L.L.C.$104K
- plus $539K from 27 others
Across 26 payments — averaging $12,306 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$297K
- Novartis$9K
- Pfizer$8K
- Regeneron$3K
- Roche TCRC, Inc.$2K
- Eli Lilly$1K
What the payments were for
- Consulting fees$547,05981%
- Speaking & faculty fees$54,7978%
- Travel & lodging$61,3569%
- Food & beverage$7,6761%
- Education$1,0250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 47 | $2,406,975 |
| AbbVie | 152 | $1,315,474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $863,104 |
| Novartis Pharma AG | 6 | $622,000 |
| Pfizer | 11 | $460,359 |
| E.r. Squibb & Sons, L.L.C. | 64 | $103,788 |
| Amgen | 58 | $87,051 |
| UCB SA | 33 | $79,377 |
| Boehringer Ingelheim International GmbH | 74 | $56,744 |
| Boehringer Ingelheim | 24 | $52,110 |
| Janssen Global Services, LLC | 39 | $45,684 |
| Johnson & Johnson | 61 | $42,304 |
| Janssen Scientific Affairs, LLC | 4 | $23,369 |
| Eli Lilly | 9 | $19,132 |
| Almirall LLC | 4 | $17,831 |
| LEO Pharma AS | 33 | $15,630 |
| Sanofi | 9 | $15,281 |
| Merck | 11 | $14,225 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $11,547 |
| Janssen Research & Development, LLC | 4 | $9,280 |
| UCB, Inc. | 7 | $9,127 |
| Sanofi-aventis U.S. LLC | 3 | $8,829 |
| Incyte Corporation | 19 | $6,437 |
| Bristol Myers Squibb | 25 | $6,346 |
| Kyowa Kirin Co., Ltd | 5 | $5,687 |
| Calliditas Therapeutics US Inc. | 2 | $5,000 |
| CSL Behring | 2 | $3,000 |
| UCB GmbH | 1 | $2,490 |
| Kyowa Kirin, Inc. | 1 | $740 |
| LEO Pharma Inc. | 4 | $633 |
| Regeneron | 3 | $319 |
| Regeneron Healthcare Solutions, Inc. | 4 | $229 |
| Dermira, Inc. | 1 | $154 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,310,256 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.
Other dermatology in New York
- Emma GuttmanNew York$35.3M
- Saakshi KhattriNew York$15.4M
- Michael CameronNew York$5.8M
- Mark LebwohlNew York$5.8M
- Andrew AlexisNew York$5.7M
- Neil SadickNew York$4.2M
- Orit MarkowitzNew York$3.7M
- Alexandra GolantNew York$3.6M
- George HanNew York$3.4M
- David CohenNew York$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.